ZEVRA THERAPEUTICS's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 0 published signal records.
ZEVRA THERAPEUTICS last closed at $11.39 (+3.55%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 12.0×. Its overall grade ranks 87 of 736 stocks in Healthcare.
About this company
ZEVRA THERAPEUTICS last closed at $11.39 (+3.55%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 87/736
Valuation grade F
Related stocks
- Purdue PharmaCustomer
Zevra의 중증 희귀질환 치료제 판매/상업화와 관련된 주요 파트너
- Jazz PharmaceuticalsCompetitor
희귀질환·중추신경계 치료제 시장에서 경쟁
- Amicus TherapeuticsCompetitor
희귀질환 치료제 중심의 경쟁사
About ZEVRA THERAPEUTICS
- What technical signals does ZEVRA THERAPEUTICS (ZVRA) have?
- ZEVRA THERAPEUTICS current technical signals: MACD bullish cross.
- Is ZEVRA THERAPEUTICS a cup-and-handle pattern?
- No. ZEVRA THERAPEUTICS has no valid Cup signal right now.
- What published figures are available for ZEVRA THERAPEUTICS?
- Market cap: $641.23M. Trailing 12 months PER: 12.0×. Latest quarter PBR: 3.21×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about ZEVRA THERAPEUTICS, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.